Development of a new method to assess organophosphate insecticides exposure
开发评估有机磷杀虫剂暴露的新方法
基本信息
- 批准号:14580564
- 负责人:
- 金额:$ 1.98万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2002
- 资助国家:日本
- 起止时间:2002 至 2003
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Since several chemicals such as organophosphate and carbamate insecticides and heavy metals inhibit cholinesterases, the tissue levels of acetylcholinesterase(AChE) in various fishes have been used as a potential biomarker for exposure to these chemicals in aquatic environments. In order to make AChE a more reliable and useful biomarker, it seems essential that a new method to assess organophosphate insecticides exposure, which is not affected by individual difference of fish in tissue levels of AChE, be developed. It is also desirable that the AChE is characterized well after purification, since catalytic properties and inhibitor sensitivities of the enzyme to various chemicals vary from species to species in general. However, there has been no characterized AChE of common fresh-water fishes. Thus in the present study, we purified and characterized AChE from body muscle of Koi carp(Cyprinus carpio), one of the fishes used for environmental monitoring in aquatic environment, and tried to develop the new method described above.At the first step, we purified the collagen-tailed asymmetric forms of AChE, the main forms in Koi carp body muscle, 79700-fold. The purified enzyme had a high specific activity of 14900μmol・min^<-1>・mg^<-1> protein and the molecular mass of the catalytic subunit was 76.8kDa. The characterizations of the purified enzyme in catalytic property, substrate specificity and inhibitor specificity demonstrate that the purified AChE from Koi carp muscle is certainly an AChE.At the second stage, we tried to produce specific polyclonal antibody to the catalytic subunit of purified Koi carp AChE, which is used for the development of the new method to assess organophosphate insecticides exposure. Unfortunately, the antibody was not obtained.
由于一些化学品,如有机磷和氨基甲酸酯类杀虫剂和重金属抑制胆碱酯酶,乙酰胆碱酯酶(AChE)在各种鱼类的组织水平已被用作一个潜在的生物标志物暴露于这些化学品在水生环境中。为了使AChE成为一种更可靠、更有用的生物标志物,有必要开发一种新的方法来评估有机磷农药暴露,该方法不受AChE组织水平个体差异的影响。还希望AChE在纯化后被很好地表征,因为酶对各种化学品的催化性质和抑制剂敏感性通常因物种而异。然而,目前还没有常见的淡水鱼类的乙酰胆碱酯酶的特征。因此,本研究以锦鲤(Cyprinus carpio)为研究对象,从锦鲤肌肉中提取AChE,并对其进行了初步的纯化和鉴定,初步建立了一种新的AChE提取方法。第一步,我们对锦鲤肌肉中主要的AChE胶原蛋白尾部不对称型进行了纯化,纯化倍数为79700倍。纯化的酶比活力为14900μmol·min^<-1>·mg^<-1>protein,催化亚基的分子量为76.8kDa。对纯化酶的催化特性、底物特异性和抑制剂特异性进行了表征,证实了锦鲤肌肉AChE是一种AChE。第二阶段,我们尝试制备针对锦鲤AChE催化亚基的特异性多克隆抗体,用于建立新的有机磷农药暴露评估方法。不幸的是,没有获得抗体。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Y.Kera, K.Mitani, T.Matsumoto, R.Sato, S.Takahashi, R.Yamada: "Acetylcholinesterase from Koi carp body muscle : tissue distribution, purification and characterization."Jpn.J.Environ.Toxicol.. 7(in press). (2004)
Y.Kera、K.Mitani、T.Matsumoto、R.Sato、S.Takahashi、R.Yamada:“来自锦鲤体肌肉的乙酰胆碱酯酶:组织分布、纯化和表征。”Jpn.J.Environ.Toxicol.. 7
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Y.Kera, K.Mitani, T.Matsumoto, R.Sato, S.Takahashi, R.Yamada: "Acetylcholinesterase from Koi carp body muscle : tissue distribution, purification and characterization."Jpn.J.Environ.Toxicpl.. (in press). (2004)
Y.Kera、K.Mitani、T.Matsumoto、R.Sato、S.Takahashi、R.Yamada:“来自锦鲤体肌肉的乙酰胆碱酯酶:组织分布、纯化和表征。”Jpn.J.Environ.Toxicpl..(
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KERA Yoshio其他文献
KERA Yoshio的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KERA Yoshio', 18)}}的其他基金
Research on novel degradation enzymes and genes essential to microbial degradation of persistent chlorinated organophosphorus triesters
微生物降解持久性氯化有机磷三酯的新型降解酶和基因研究
- 批准号:
20310039 - 财政年份:2008
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Isolation and characterization of bacteria degrading chlorinated organophosphate esters, persistent organophosphorus compounds
降解氯化有机磷酸酯、持久性有机磷化合物的细菌的分离和表征
- 批准号:
16310054 - 财政年份:2004
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Assessment of environmental endocrine disruption with plasma concentration of vitellogenin in Koi carp of rivers and wetland sites.
通过河流和湿地锦鲤血浆卵黄蛋白原浓度评估环境内分泌干扰。
- 批准号:
11839007 - 财政年份:1999
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似国自然基金
基于DNA甲基化交互网络的癌症hallmark挖掘及其在癌症转移biomarker筛选中的应用
- 批准号:61602201
- 批准年份:2016
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
血清miRNAs成为一种新的biomarker在PD诊断中的价值和LRRK2基因调控的机制研究
- 批准号:81170309
- 批准年份:2011
- 资助金额:50.0 万元
- 项目类别:面上项目
非小细胞肺癌Biomarker的Imaging MS研究新方法
- 批准号:30672394
- 批准年份:2006
- 资助金额:30.0 万元
- 项目类别:面上项目
相似海外基金
酸化ストレス応答アポトーシス誘導蛋白のUCに対する新規Biomarker探索と治療への展開
寻找治疗 UC 的氧化应激反应性凋亡诱导蛋白的新生物标志物并开发治疗方法
- 批准号:
24K11919 - 财政年份:2024
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
肝内胆管癌新規Biomarkerの同定及び癌周囲間質を標的とした新規治療開発
鉴定肝内胆管癌的新型生物标志物并开发针对癌周基质的新疗法
- 批准号:
24K19350 - 财政年份:2024
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
収縮能が保たれた心不全の機械学習分類とmicroRNAなどのbiomarkerの探索
机器学习对具有保留收缩性的心力衰竭进行分类并搜索 microRNA 等生物标志物
- 批准号:
24K19007 - 财政年份:2024
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Development of a predictive biomarker for Parkinson's disease
帕金森病预测生物标志物的开发
- 批准号:
MR/Y019415/1 - 财政年份:2024
- 资助金额:
$ 1.98万 - 项目类别:
Research Grant
Sleep and circadian dysfunction in ageing and neurodegeneration: a life course and biomarker study of the British 1946 birth cohort.
衰老和神经退行性疾病中的睡眠和昼夜节律功能障碍:对英国 1946 年出生队列的生命历程和生物标志物研究。
- 批准号:
MR/Y009452/1 - 财政年份:2024
- 资助金额:
$ 1.98万 - 项目类别:
Fellowship
Biomarker-Based Platform for Early Diagnosis of Chronic Liver Disease to Enable Personalized Therapy (LIVERAIM)
基于生物标志物的慢性肝病早期诊断平台,以实现个性化治疗(LIVERAIM)
- 批准号:
10087822 - 财政年份:2024
- 资助金额:
$ 1.98万 - 项目类别:
EU-Funded
Enhanced stratification of COPD patients via integration of a digitally enabled biomarker Point-of-Care test within a Remote Patient Monitoring tool
通过在远程患者监测工具中集成数字化生物标志物即时检测,增强 COPD 患者的分层
- 批准号:
10098600 - 财政年份:2024
- 资助金额:
$ 1.98万 - 项目类别:
Collaborative R&D
QuBIE: Quantitative Biomarker Identification for Non-Endoscopic Prediction and Monitoring of Treatment Response in Eosinophilic Oesophagitis
QuBIE:用于非内镜预测和监测嗜酸性食管炎治疗反应的定量生物标志物鉴定
- 批准号:
10083253 - 财政年份:2024
- 资助金额:
$ 1.98万 - 项目类别:
Collaborative R&D
膵癌腫瘍内線維化に着目した術前化学療法効果予測に関する画像biomarkerの確立
建立预测胰腺癌瘤内纤维化术前化疗效果的影像生物标志物
- 批准号:
24K18824 - 财政年份:2024
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
I-Corps: Developing A Blood-Based Biomarker for the Detection and Monitoring of Amyotrophic Lateral Sclerosis
I-Corps:开发一种基于血液的生物标志物,用于检测和监测肌萎缩侧索硬化症
- 批准号:
2317745 - 财政年份:2023
- 资助金额:
$ 1.98万 - 项目类别:
Standard Grant